Last reviewed 2026-04-19 · How we verify

Povidone-Iodine 0.6% NS

DR. MALA KHAN · Phase 2 active Small molecule

Povidone-Iodine 0.6% NS is a Small molecule drug developed by DR. MALA KHAN. It is currently in Phase 2 development. Also known as: Povidone-Iodine 0.6%.

At a glance

Generic name	Povidone-Iodine 0.6% NS
Also known as	Povidone-Iodine 0.6%
Sponsor	DR. MALA KHAN
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Virucidal Effect of Povidone Iodine on COVID-19 In-Vivo (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Povidone-Iodine 0.6% NS CI brief — competitive landscape report
Povidone-Iodine 0.6% NS updates RSS · CI watch RSS
DR. MALA KHAN portfolio CI

Frequently asked questions about Povidone-Iodine 0.6% NS

What is Povidone-Iodine 0.6% NS?

Povidone-Iodine 0.6% NS is a Small molecule drug developed by DR. MALA KHAN.

Who makes Povidone-Iodine 0.6% NS?

Povidone-Iodine 0.6% NS is developed by DR. MALA KHAN (see full DR. MALA KHAN pipeline at /company/dr-mala-khan).

Is Povidone-Iodine 0.6% NS also known as anything else?

Povidone-Iodine 0.6% NS is also known as Povidone-Iodine 0.6%.

What development phase is Povidone-Iodine 0.6% NS in?

Povidone-Iodine 0.6% NS is in Phase 2.

Manufacturer: DR. MALA KHAN — full pipeline
Also known as: Povidone-Iodine 0.6%